Suchergebnisse - "Kabré, Zachari"

PubPharm (10)

1

Ex vivo drug susceptibility and resistance mediating genetic polymorphisms of Plasmodium falciparum in Bobo-Dioulasso, Burkina Faso

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Somé, A. | Conrad, M. | Kabré, Z. | +12

2

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children : a multicentre, double-blind, randomised, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Datoo, M. | Dicko, A. | Tinto, H. | +117

3

Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC): A Quantitative Study in Burkina Faso, Mali, and Niger

enthalten in: Preprints.org | 2022

von Somé, A. | Zongo, I. | Sagara, I. | +14

4

Factors Influencing Second and Third Dose Observance during Seasonal Malaria Chemoprevention (SMC) : A Quantitative Study in Burkina Faso, Mali and Niger

enthalten in: Tropical medicine and infectious disease | 2022

von Somé, A. | Zongo, I. | Sagara, I. | +14

5

Hepatic safety of repeated treatment with pyronaridine-artesunate (PA) versus artemether-lumefantrine (AL) in patients with uncomplicated malaria: A secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso.

enthalten in: ResearchSquare.com | 2022

von Compaoré, Y. | Zongo, I. | Somé, A. | +11

6

Hepatic safety of repeated treatment with pyronaridine-artesunate (PA) versus artemether-lumefantrine (AL) in patients with uncomplicated malaria: A secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso

enthalten in: ResearchSquare.com | 2022

von Compaoré, Y. | Zongo, I. | Somé, A. | +11

7

Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso

enthalten in: ResearchSquare.com | 2022

von Compaoré, Y. | Zongo, I. | Somé, A. | +11

8

Hepatic safety of repeated treatment with pyronaridine-artesunate versus artemether-lumefantrine in patients with uncomplicated malaria : a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso

enthalten in: Malaria journal | 2021

von Compaoré, Y. | Zongo, I. | Somé, A. | +11

9

Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso

enthalten in: Malaria journal | 2021

von Compaoré, Y. | Zongo, I. | Somé, A. | +11

10

Investigating selected host and parasite factors potentially impacting upon seasonal malaria chemoprevention in Bama, Burkina Faso

in: Malaria Journal | 2020

von Fabrice A. Somé | Thomas Bazié | Hanna Y. Ehrlich | +10

1
[1]